Aaron Aday, MD
Basic profileCardiovascular Disease
Aaron Aday is a Cardiology physician. ClinicalTrials.gov lists 4 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics need a complete publication history and a confident author match. We omit them when either check fails. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
- Survey on Physical Activity and Qualify of Life in Fibromuscular Dysplasia
Sponsor: Vanderbilt University Medical Center
- Best Practice Advisory to Initiate High-Intensity Statin Therapy in Patients With Peripheral Artery Disease
Sponsor: Vanderbilt University Medical Center
- The Impact of Factor Xa Inhibition on Thrombosis, Platelet Activation, and Endothelial Function in Peripheral Artery Disease
Sponsor: Vanderbilt University Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- NovartisProgram year20252 paymentsResearch$15,789
- Merck Sharp & Dohme LLCProgram year202517 payments$10,792
- TACTILE SYSTEMS TECHNOLOGY INCProgram year20251 payment$2,000
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
68.6%Statin26.3%Atorvastatin Calcium74%Rosuvastatin Calcium26%Part D≥24 patientsBeta blocker14.3%Metoprolol Succinate59%Carvedilol41%Part D<11 patients+ 5 more classes in this area
Blood & clotting
31.4%Factor Xa inhibitor24.5%Xarelto56%Eliquis45%Part D<11 patientsVitamin K antagonist3.6%Warfarin Sodium100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2020–2025 per NIH RePORTER. The latest:
- The Impact of Thrombosis and Antithrombotic Therapy on Peripheral Artery Disease
Vanderbilt University Medical Center
FY2025$185,436K23HL151871 - The Impact of Thrombosis and Antithrombotic Therapy on Peripheral Artery Disease
Vanderbilt University Medical Center
FY2024$185,436K23HL151871 - The Impact of Thrombosis and Antithrombotic Therapy on Peripheral Artery Disease
Vanderbilt University Medical Center
FY2023$185,436K23HL151871
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Martin Leon, MD
Columbia University Irving Medical Center
Gregg Fonarow, MD
Ronald Reagan UCLA Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”